Company Lannett Company, Inc. Nyse MKT
Equities
LCI
US5160121019
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Crew
CEO | Chief Executive Officer | 63 | 18-01-01 |
Kristie Stephens
CTO | Chief Tech/Sci/R&D Officer | - | 98-12-31 |
Michael Block
PRN | Corporate Officer/Principal | - | 11-12-31 |
Corporate Officer/Principal | 65 | 18-05-06 | |
Grant Brock
PRN | Corporate Officer/Principal | - | 18-01-31 |
Samuel Israel
LAW | General Counsel | 63 | 17-07-16 |
John Abt
PRN | Corporate Officer/Principal | 59 | 15-03-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Todd Clegg
BRD | Director/Board Member | - | - |
Jeffrey Goldberg
CHM | Chairman | - | 23-06-15 |
Jason Shandell
BRD | Director/Board Member | 50 | 23-06-15 |
Timothy Crew
CEO | Chief Executive Officer | 63 | 18-01-01 |
James Bauersmith
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,218,128 | 9,231,253 ( 82.29 %) | 437,941 ( 3.904 %) | 82.29 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+20.75% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+12.00% | 13.64B | |
+39.48% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |